Andrew Kassick

Title: The Innovations of Andrew Kassick

Introduction

Andrew Kassick is a notable inventor based in Wexford, PA (US). He has made significant contributions to the field of polymer science, particularly in the development of innovative drug delivery systems. With a total of 3 patents, Kassick's work focuses on addressing critical issues related to opioid treatment and polymer modification.

Latest Patents

Kassick's latest patents include "Covalent modification and controlled delivery of mu opioid receptor antagonists" and "Hydrophilic polyarylene ether ketone polymer and methods of forming same." The first patent describes polymer conjugates that consist of a hydrophobic biodegradable polymer covalently attached to a mu opioid receptor (MOR) antagonist. This innovative delivery system aims to effectively prevent or mitigate the toxic effects of synthetic opioids. The second patent discloses a modified polymer that exhibits increased hydrophilicity, along with a method for its preparation. This polymer features a plurality of repeating units, with some units containing a hydrophilic N-substituted imine derived from a ketone.

Career Highlights

Andrew Kassick is currently associated with the Allegheny-Singer Research Institute, where he continues to advance his research in polymer science and drug delivery systems. His work has the potential to significantly impact the medical field, particularly in the treatment of opioid addiction and pain management.

Collaborations

Kassick collaborates with talented individuals such as Saadyah Averick and Boyle Cheng. Their combined expertise contributes to the innovative research and development efforts at the Allegheny-Singer Research Institute.

Conclusion

Andrew Kassick's contributions to the field of polymer science and drug delivery systems highlight his role as a significant inventor. His innovative patents address critical challenges in opioid treatment, showcasing the importance of research and collaboration in advancing medical science.